
|Videos|December 13, 2022
Importance of Clinical Trial Data, Disease Control, and QoL in Atopic Dermatitis Management
Author(s)Raj Chovatiya, MD, PhD, MSCI, Neal Bhatia, MD
Raj Chovatiya, M.D., Ph.D. and Neal Bhatia, MD comment on the importance of assessing a treatment’s available clinical trial data, ability to control disease severity, and QoL impacts when assessing atopic dermatitis treatment options.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
KT-621 Produces 98% STAT6 Degradation in AD Patients
3
DeepSeek-R1 Outperforms ChatGPT-4o in Urticaria Clinical Queries
4
Abeona Initiates First Commercial Treatment of Zevaskyn for RDEB
5























